City's pilot project to improve public health safety is first of its
kind in Canada
TORONTO, Sept. 8, 2014 /CNW/ - Pfizer Canada today announced its
participation in an unprecedented pilot project in Canada that could
eventually make EpiPen® and EpiPen® Jr. (epinephrine) Auto-Injectors
available to every restaurant and food court in Hamilton, Ontario.
As part of a ground-breaking municipal project involving Hamilton city
council, local health officials and McMaster University, Pfizer is
contributing by donating the EpiPen® auto-injectors to Hamilton's
downtown Jackson Square mall as a precaution for restaurant customers
who might need immediate assistance during an emergency treatment of
anaphylactic reactions related to food allergies.
"This is a very exciting and important new health safety initiative and
Pfizer is proud to have the opportunity to partner with the city of
Hamilton to make EpiPen® and EpiPen® Jr. easily and quickly accessible
to people who are visiting the mall's restaurants and food court every
day," said Allen Van der Wee, General Manager, Global Established
Pharma Business, at Pfizer Canada.
The one-year pilot project was initiated by the Rotary Club of Anacaster
and Hamilton City Councillor, Lloyd Ferguson, in the wake of public
concerns raised following the death of a 12-year-old girl in a
Burlington, Ontario food court last year. Jackson Square security staff
will now begin wearing EpiPen® Auto-Injectors on their belts.
Pfizer had donated 12 adult and junior versions of its EpiPen®
auto-injectors to the project and Hamilton City Council has agreed to
dedicate $82,000 to the pilot project, part of which will go to
Anaphylaxis Canada to train local security staff on the proper use of
EpiPen® while the other part will support the McMaster University
"We hope this pilot project comes as very positive news to local
residents and we are very excited to see it prove successful," said
Hamilton area, Ancaster AM Rotarians and project contributors, Marty
Schure and Dr. Frank Stechey. "Hamilton is the first municipality in
Canada to launch a project of this kind and we hope to gain useful
insights that will help to improve health safety in public places such
as restaurants and food operations in malls. We are pleased to be
working with the City of Hamilton, McMaster University, Anaphylaxis
Canada and First Real Properties on this important initiative."
"Ultimately, the goal is to see this innovative project implemented
city-wide, in order to improve health safety for people who live with
potentially life-threatening allergies and who could face an emergency
situation requiring an immediate response."
McMaster University will review results of the project to assess key
factors such as usage and consumer confidence and share their findings
with City officials to make informed decisions on the initiative.
Food allergies are recognized as a growing public health issue.i According to Health Canada, food allergies affect as many as 5-6 per
cent of young children and 3-4 per cent of adults in Canada.ii Anaphylaxis Canada estimates that one in two Canadians know someone
with a serious food allergy.i For Step-By-Step Instructions On How To Use Your EpiPen® Auto-Injector,
visit the EpiPen® Canada YouTube Page: https://www.youtube.com/channel/UCf_JC-iAMUhHvvD37bBOQiQ
About Pfizer Canada
It is the Canadian operation of Pfizer Inc., one of the world's leading
biopharmaceutical companies. The company is one of the largest
contributors to health research in Canada. Pfizer's diversified health
care portfolio includes biologic and small molecule medicines and
vaccines for humans, and many of the world's best known consumer
products. To learn more about Pfizer Canada, visit pfizer.ca or you can follow us on Twitter (twitter.com/PfizerCA) or Facebook (facebook.com/Pfizer.Canada).
EpiPen and EpiPen Jr (0.3 and 0.15 mg epinephrine) Auto-injectors
("EpiPen") are indicated for the emergency treatment of anaphylactic
reactions in patients who are determined to be at increased risk for
anaphylaxis, including individuals with a history of anaphylactic
reactions. The EpiPen Auto-Injector is a disposable, pre-filled
automatic injection device that administers epinephrine in the event of
a severe allergic reaction. After using EpiPen, you must seek
immediate medical attention or go to the emergency room. For the next
48 hours, you must stay close to a healthcare facility or be able to
call 9-1-1. For more information about EpiPen, please visit www.epipen.ca.
i Anaphylaxis Canada, 2012. Retrieved Sept. 3, 2014. Available at: http://www.anaphylaxis.ca/en/i_want/anaphylaxis101/key_facts.html
ii Health Canada. Retrieved Sept. 3, 2014. Available at http://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/allerg-eng.php
Image with caption: "EpiPen® and EpiPen® Jr (epinephrine) Auto-Injectors (CNW Group/Pfizer Canada Inc.)". Image available at: http://photos.newswire.ca/images/download/20140908_C8652_PHOTO_EN_42685.jpg
Image with caption: "EpiPen(R) (epinephrine) Auto-Injector (CNW Group/Pfizer Canada Inc.)". Image available at: http://photos.newswire.ca/images/download/20140908_C8652_PHOTO_EN_42661.jpg
Image with caption: "EpiPenR Jr (epinephrine) Auto-Injector (CNW Group/Pfizer Canada Inc.)". Image available at: http://photos.newswire.ca/images/download/20140908_C8652_PHOTO_EN_42662.jpg
PDF available at: http://stream1.newswire.ca/media/2014/09/08/20140908_C8652_DOC_EN_42687.pdf
SOURCE: Pfizer Canada Inc.
For further information:
Pfizer Canada Inc.